Valion Bio files Form 8-K
Valion Bio filed a Form 8-K on October 29.
Related stories
Kolmar Korea to Hold Q3 Results Call for Analysts on Nov. 6
Kolmar Korea plans to present its third-quarter results on an analyst conference call at 10:30 a.m. on Nov. 6, 2026.
M impact | EQUITY | Oct 30, 2026, 12:21 AM UTC
Kolmar Korea to Host Q3 Results Call for Analysts
M impact | EQUITY | Oct 30, 2026, 12:21 AM UTC
Carrier Global Publishes Q3 2026 Earnings Call Transcript
Carrier Global published its Q3 2026 earnings call transcript.
M impact | EQUITY | Oct 30, 2026, 12:20 AM UTC
Vartan Korajian Acquires Tana Resources Common Shares
M impact | EQUITY | Oct 30, 2026, 12:20 AM UTC
Doosan Enerbility Wins U.S. SMR Component Order
M impact | EQUITY | Oct 30, 2026, 12:18 AM UTC
Bambusa Therapeutics Prices Upsized IPO
M impact | EQUITY | Oct 30, 2026, 12:16 AM UTC